{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:02:17Z","timestamp":1776740537175,"version":"3.51.2"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\u201cHepatic superscan\u201d could be caused by a variety of etiologies. Here we report a 68-year-old woman with a medication history of cefoperazone and azithromycin for pneumonia recently who underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT to detect underlying malignancy due to unexplained liver damage and fever of unknown origin. Unexpectedly, \u201chepatic superscan\u201d without morphologic changes was noted. Unfortunately, aggressive treatment did not reverse the damaged liver function, and the patient rapidly died. Drug-induced fulminant hepatitis was diagnosed clinically. Our case demonstrates that fulminant hepatitis could result in \u201chepatic superscan\u201d on <jats:sup>18<\/jats:sup>F-FDG PET despite negative findings on the ultrasonography, CT, and MRI.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004931","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:00:27Z","timestamp":1700258427000},"page":"101-103","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["\u201cHepatic Superscan\u201d Revealed on 18F-FDG PET Due to Drug-Induced Fulminant Hepatitis"],"prefix":"10.1097","volume":"49","author":[{"given":"Guigang","family":"Qiu","sequence":"first","affiliation":[{"name":"Hepatobiliary Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Shao","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Zigong First People\u2019s Hospital, Zigong Academy of Medical Sciences, Zigong, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Third Hospital, Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11604-022-01306-w","article-title":"Optimal use of the FDG-PET\/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review","volume":"40","year":"2022","journal-title":"Jpn J Radiol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2013.07.001","article-title":"Drug-induced acute liver failure","volume":"17","year":"2013","journal-title":"Clin Liver Dis"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2146\/ajhp080687","article-title":"Azithromycin-induced liver injury","volume":"67","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3346\/jkms.2010.25.8.1256","article-title":"Metabolic super scan in 18F-FDG PET\/CT imaging","volume":"25","year":"2010","journal-title":"J Korean Med Sci"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/RLU.0000000000001080","article-title":"Skeletal \u201csuperscan\u201d on 18F-choline PET\/CT: cases of myeloproliferative disease","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/RLU.0b013e31827a22ae","article-title":"Nephrogenic systemic fibrosis in a patient with renal failure demonstrating a \u201creverse superscan\u201d on bone scintigraphy","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","first-page":"149","article-title":"Peritoneal super scan on 18F-FDG PET\/CT in two patients with lymphoma","volume":"8","year":"2020","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11307-023-01820-x","article-title":"A comparative study of 18F-FAPI-42 and 18F-FDG PET\/CT for evaluating acute kidney injury in cancer patients","volume":"25","year":"2023","journal-title":"Mol Imaging Biol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/1450-1147.167581","article-title":"Detection of diffuse infiltrative primary hepatic lymphoma on FDG PET-CT: hallmarks of hepatic superscan","volume":"15","year":"2016","journal-title":"World J Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/RLU.0000000000004152","article-title":"Hepatic angiosarcoma with diffuse increased 18F-FDG uptake on PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1097\/RLU.0000000000002211","article-title":"Diffuse liver metastasis from nasopharyngeal carcinoma found by 18F-FDG PET\/CT scans","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/RLU.0000000000003044","article-title":"FDG hepatic superscan due to metastatic infiltration of prostate cancer","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00003072-200410000-00005","article-title":"Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin\u2019s disease: hepatic \u2018superscan\u2019","volume":"29","year":"2004","journal-title":"Clin Nucl Med"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/RLU.0000000000002134","article-title":"\u201cHepatic superscan\u201d in a patient with hepatosplenic alphabeta T-cell lymphoma: 18F-FDG PET\/CT findings","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/RLU.0000000000000413","article-title":"18F-FDG hepatic superscan in a patient with chronic myeloid leukemia","volume":"39","year":"2014","journal-title":"Clin Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1007\/s00259-016-3399-0","article-title":"18F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib17-20250621","first-page":"20190097","article-title":"Hot liver on 18F-FDG PET\/CT imaging\u2014a quandary for oncoradiologists in South Asia","volume":"6","year":"2020","journal-title":"BJR Case Rep"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.11622\/smedj.2013237","article-title":"Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography","volume":"55","year":"2014","journal-title":"Singapore Med J"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RLU.0000000000000723","article-title":"Diffuse hepatic FDG activity from nonmalignant etiologies","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/RLU.0000000000000605","article-title":"Diffuse hepatic amebiasis detected by FDG PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s13139-012-0130-3","article-title":"A case of acute Q fever hepatitis diagnosed by F-18 FDG PET\/CT","volume":"46","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3348\/kjr.2011.12.5.634","article-title":"18F-FDG PET\/CT in primary AL hepatic amyloidosis associated with multiple myeloma","volume":"12","year":"2011","journal-title":"Korean J Radiol"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/RLU.0b013e318217ae7c","article-title":"A case of secondary hemochromatosis with high uptake of liver in F-18 FDG PET\/CT imaging","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/RLU.0000000000000606","article-title":"Ipilimumab-induced hepatitis on 18F-FDG PET\/CT in a patient with malignant melanoma","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib25-20250621","first-page":"179","article-title":"Unusual diffuse liver 18F-FDG uptake in melanoma patient treated by ipilimumab","volume":"20","year":"2017","journal-title":"Hell J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:04:04Z","timestamp":1750532644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004931","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}